361 results
Hotline: advances in coronary physiology
14 May 2024 – From EuroPCR 2024
This hotline session explores the latest advancements in coronary physiology and their implications for percutaneous coronary intervention (PCI). Topics covered include the influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI, the prognostic value of myocardial ischemic burden in STEMI...
Innovating techniques for the treatment of coronary artery disease
14 May 2024 – From EuroPCR 2024
This session showcases innovative techniques for the treatment of coronary artery disease, including minimum contrast PCI with guide extension catheter and IVUS co-registration, management of iatrogenic aortic dissection using 3D-hologram and computational fluid dynamics, a novel tunnelling technique for huge coronary bypass graft aneurysms, and a...
PCI: from basics to robots
14 May 2024 – From EuroPCR 2024
This session covers a wide range of topics in percutaneous coronary intervention (PCI), from fundamental aspects to the latest advancements. It includes discussions on non-fasting versus fasting before interventional procedures, radial artery puncture hemostasis, ultrasound-guided transfemoral puncture in complex PCI, the use of uninterrupted direct-acting oral...
After ORBITA 2, what is the role of PCI in the contemporary management of patients with angina and coronary disease?
16 May 2024 – From EuroPCR 2024
Emanuele Barbato interviews Rasha Al-Lamee, the principal investigator of the ORBITA 2 trial, about the current role of percutaneous coronary intervention (PCI). Unlike ORBITA 1, ORBITA 2 focused on the effects of angioplasty as a monotherapy, without prior anti-angina treatment. The results showed that angioplasty improved symptoms...
What is the optimal management of patients with coronary artery disease and left ventricle dysfunction in 2024?
15 May 2024 – From EuroPCR 2024
Check out this EuroPCR 2024 interview between Valeria Paradies and Vasileios Panoulas to learn about CAD patients with LV dysfunction. Gain insights from the REVIVED trial, which shows that very stable, asymptomatic patients can be treated with medical therapy, including the four pillars of heart failure...
PCI for in-stent restenosis complicated by neoatherosclerosis dissection
30 Apr 2024
Did you know that neoatherosclerosis (in the context of in-stent restenosis (ISR)) can suffer dissection, just like any native coronary artery, when balloon dilatation is performed?
Author
Coronary artery rupture in hybrid treatment
12 Apr 2024
Find out more about the step-by-step approach to effectively manage coronary artery rupture using prolonged balloon inflation.
Author
Ticagrelor vs Clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome
15 Mar 2024
The results of this sub-analysis of the ALPHEUS trial show that complex PCI criteria are present in a large percentage of patients with chronic coronary syndrome and are associated with higher rates of both periprocedural events and MACE than non-complex PCI.
Reviewer
Reviewer
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
Coronary physiology guidance vs conventional angiography for optimization of percutaneous coronary intervention: the AQVA-II Trial
24 Jan 2024
The primary aim of this study was to demonstrate the superiority of physiology-guided PCI, using either angiography or microcatheter-derived FFR, over conventional angiography-based PCI in complex high-risk indicated procedures (CHIPs) in obtaining a higher FFR post-PCI.
Reviewer
